You are required to be logged in to access the full website
Click here if you have forgotten your username or password
28 October 2024 - Healthcare company Organon (NYSE: OGN) announced on Monday that it has finalised its acquisition of Dermavant Sciences Ltd, a provider of therapeutic solutions in immuno-dermatology, expanding its dermatology offerings with VTAMA (t...
28 October 2024 - Senzime (Nasdaq Stockholm: SEZI) (OTCQX: SNZZF), a provider of perioperative patient monitoring solutions, announced on Monday that it has launched its advanced TetraGraph system for quantitative train-of-four (TOF) monitoring at AN...
28 October 2024 - Medicine company Eli Lilly and Company (NYSE: LLY) announced on Monday that it will pay a fourth-quarter 2024 dividend of USD1.30 per share on its common stock.This dividend is payable on 10 December 2024 to shareholders of record a...
28 October 2024 - AI-driven biotherapeutic research and technology company ImmunoPrecise Antibodies Ltd (NASDAQ: IPA) announced on Monday that it has contributed to a pivotal Mayo Clinic-led study on mitochondrial health, recently published in Autoph...
28 October 2024 - Pharmaceutical industry company Johnson & Johnson (NYSE:JNJ) on Monday reported positive results from the Phase 3 GRAVITI study of TREMFYA (guselkumab), the first and only IL-23 inhibitor, for treating adults with moderately to ...
M2 Pharma brings you breaking news and information on the
global pharmaceuticals industry, helping you to stay one step ahead of the competition.
Click here to subscribe
Click here to subscribe